Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Bogdan Popescu
The session started with a conference by Dr T. Kukulski (Zabrze, Poland) who gave an overview about how to evaluate left ventricular (LV) diastolic function in clinical practice.He stressed the importance of the topic in the context of the high prevalence of heart failure with preserved ejection fraction. He then discussed the different modalities applied (structural and Doppler evaluation), with the pros and cons, putting technical aspects into clinical perspective.This conference was followed by 4 presentations based on challenging clinical cases.
Dr A. Brown (Dublin, Ireland) presented four cases to illustrate the common challenge of differentiating constriction from restriction. She discussed in a clear way the physiopathology behind the different echo signs used in this regard. The critical importance of a comprehensive approach including a detailed clinical assessment was underlined. The role of non-echo imaging modalities was also discussed.
Dr F. Flachskampf (Uppsala, Sweden) commented on the assessment of diastolic function in patients with LV systolic dysfunction. In such a setting, assessment mainly aims to estimate the LV filling pressures. The role of different echo parameters was discussed in the context of two illustrative cases. In cases where several parameters are in the intermediate grey-zone, the potential role of calculating the TE-e’ interval was discussed.
Dr J.E. Moller (Odense, Denmark) presented the assessment of diastolic function in patients with valvular heart disease. While in aortic stenosis the role of the E/e’ ratio and LA volume are established and may provide prognostic information, few data have been validated in aortic regurgitation. In patients with mitral regurgitation or mitral stenosis, many of the conventional echo parameters cannot be applied. The role of measuring the TE-e’ interval was again discussed as an option in such patients.
Finally, Dr A. Iliesiu (Bucharest, Romania) commented on the assessment of diastolic function in patients with atrial fibrillation. Many of the usual parameters (e.g. LA volume, parameters based on the A or Ar waves) cannot be used in this setting. Thus, the importance of a comprehensive approach, performed at a controlled heart rate averaging several beats and using a combination of parameters was underlined and illustrated with several interesting clinical cases.
Bogdan A. Popescu, Bucharest, Romania
Diastole in clinical practice
© 2017 European Society of Cardiology. All rights reserved